Pfizer Newsroom

Wolfe Research Initiates Pfizer at Underperform With $25 Price Target

MT NewswiresNov 15 06:05 ET

Pfizer Analyst Ratings

BenzingaNov 15 05:57 ET

Wolfe Research Downgrades Pfizer(PFE.US) to Sell Rating, Announces Target Price $25

Moomoo NewsNov 14 16:30 ET

Pfizer Initiated With an Underperform at Wolfe Research

TipRanksNov 14 16:25 ET

UBS Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31

Moomoo NewsNov 14 07:35 ET

UBS Remains a Hold on Pfizer (PFE)

TipRanksNov 14 06:38 ET

CFRA Upgrades Pfizer(PFE.US) to Buy Rating, Cuts Target Price to $30

Moomoo NewsNov 13 02:31 ET

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsNov 12 08:33 ET

Jefferies Remains a Buy on Pfizer (PFE)

TipRanksNov 12 08:10 ET

Daiwa Securities Adjusts Pfizer's Price Target to $28 From $34, Keeps Outperform Rating

MT NewswiresNov 6 05:24 ET

Pfizer's Ponsegromab: A Promising Yet Uncertain Opportunity Influencing Hold Rating

TipRanksNov 5 00:42 ET

Evercore Maintains Pfizer(PFE.US) With Buy Rating

Moomoo NewsNov 4 08:31 ET

Truist Financial Maintains Pfizer(PFE.US) With Buy Rating

Moomoo NewsNov 4 07:35 ET

Barclays Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Moomoo NewsNov 4 04:33 ET

UBS Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $31

Moomoo NewsNov 1 16:31 ET

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $31 to $33

Moomoo NewsOct 31 09:20 ET

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $30 to $36

Moomoo NewsOct 30 09:12 ET

Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating

Moomoo NewsOct 29 08:33 ET

Moderna Stock Price Target Slashed. It's About Vaccines. -- Barrons.com

Barron'sOct 28 07:53 ET

Pfizer Analyst Ratings

BenzingaOct 25 11:56 ET